GelStat Corp. on Wednesday announced that it has closed the acquisition of CBD Life Sciences.
GelStat announced its intent to acquire the rights to multiple products from Larry Gershman.
GelStat Corporation announced that it has retained List Services Corporation to manage all branding and marketing efforts for GelStat and its products, GelStat Migraine and GelStat Sleep.
GelStat is primed to grow its OTC remedy business, according to a letter to shareholders and prospective investors released Tuesday.
GelStat Corp. on Tuesday announced it has retained Scarsdale Equities as its financial adviser to explore various strategic alternatives.